| Characteristic | Phase I | Phase II | Phase III | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Sources
Release date
March 2025
Region
Worldwide
Survey time period
As of January 1, 2025
Supplementary notes
The statistic describes the distribution of 182 active phase 1, 2, and 3 trials, as of January 1, 2025.Â
* Includes academic medical centers/NIH and public-private partnerships (PPP).
Citation formats









